Education
About Us
Working with TipRanks
Follow Us
National Health Investors (NHI)
NYSE:NHI
NHI Analyst Ratings
Moderate Buy
2 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NHI Stock 12 Month Forecast
Average Price Target
$78.40
▲(5.77% Upside)
| Highest Price Target$88.00 | Average Price Target$78.40 | Lowest Price Target$66.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
BMO Capital
Reiterated
03/24/25
Truist Financial
Reiterated
03/19/25
Wedbush
Reiterated
03/17/25
Wells Fargo
Reiterated
03/10/25
Jefferies
Assigned
01/01/25
Bank of America Securities
$92→$91
Buy
22.77%
Upside
Reiterated
11/11/24
National Health Investors price target lowered to $91 from $92 at BofANational Health Investors price target lowered to $91 from $92 at BofA
Deutsche Bank
$69→$90
Buy
21.42%
Upside
Reiterated
08/27/24
National Health Investors (NHI) PT Raised to $90 at Deutsche BankDeutsche Bank analyst Omotayo Okusanya raised the price target on National Health Investors (NYSE: NHI) to $90.00 (from $69.00) while maintaining a Buy rating.
KeyBanc
―
Hold
―
Assigned
08/20/24
KeyBanc Sticks to Their Hold Rating for National Health Investors (NHI)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
BMO Capital
Reiterated
03/24/25
Truist Financial
Reiterated
03/19/25
Wedbush
Reiterated
03/17/25
Wells Fargo
Reiterated
03/10/25
Jefferies
Assigned
01/01/25
Bank of America Securities
$92→$91
Buy
22.77%
Upside
Reiterated
11/11/24
National Health Investors price target lowered to $91 from $92 at BofANational Health Investors price target lowered to $91 from $92 at BofA
Deutsche Bank
$69→$90
Buy
21.42%
Upside
Reiterated
08/27/24
National Health Investors (NHI) PT Raised to $90 at Deutsche BankDeutsche Bank analyst Omotayo Okusanya raised the price target on National Health Investors (NYSE: NHI) to $90.00 (from $69.00) while maintaining a Buy rating.
KeyBanc
―
Hold
―
Assigned
08/20/24
KeyBanc Sticks to Their Hold Rating for National Health Investors (NHI)
NHI Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
0
0
0
0
0
Buy
4
2
2
1
4
Hold
5
6
6
4
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
8
8
5
8
Each month's total comprises the sum of three months' worth of ratings.
NHI Financial Forecast
NHI Stock Forecast FAQ
What is NHI’s average 12-month price target, according to analysts?
Based on analyst ratings, National Health Investors’s 12-month average price target is $78.40.
What is NHI’s upside potential, based on the analysts’ average price target?
National Health Investors has 5.77% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NHI a Buy, Sell or Hold?
National Health Investors has a consensus rating of Moderate Buy which is based on 2 buy ratings, 3 hold ratings and 0 sell ratings.
What is National Health Investors’s price target?
The average price target for National Health Investors is $78.40. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $88.00 ,the lowest forecast is $66.00. The average price target represents 5.77% Increase from the current price of $74.12.
The highest analyst price target is $88.00 ,the lowest forecast is $66.00. The average price target represents 5.77% Increase from the current price of $74.12.
What do analysts say about National Health Investors?
National Health Investors’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of NHI?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.